Adenosine and dopamine signaling exert opposite effects in the basal ganglia, a brain region involved in sensory-motor integration. Thus, adenosine agonists induce motor depression and adenosine antagonists, such as caffeine, produce motor activation (1). These opposite effects result from specific antagonistic interactions between subtypes of adenosine and dopamine receptors in the striatum, the main input structure of the basal ganglia. In fact, striatal dopamine receptors and, to some extent, adenosine receptors are segregated in the two main populations of ␥-aminobutyric acid (GABA) efferent neurons. 
Adenosine and dopamine signaling exert opposite effects in the basal ganglia, a brain region involved in sensory-motor integration. Thus, adenosine agonists induce motor depression and adenosine antagonists, such as caffeine, produce motor activation (1) . These opposite effects result from specific antagonistic interactions between subtypes of adenosine and dopamine receptors in the striatum, the main input structure of the basal ganglia. In fact, striatal dopamine receptors and, to some extent, adenosine receptors are segregated in the two main populations of ␥-aminobutyric acid (GABA) efferent neurons. Striopallidal neurons express dopamine receptors predominantly of the D 2 subtype (D 2 R) 1 and the highest density of adenosine A 2A receptors (A 2A R) in the brain (2, 3) . In the rat, the strionigro-strioentopeduncular neurons contain dopamine receptors predominantly of the D 1 subtype (D 1 R) and express exclusively adenosine receptors of the A 1 subtype (A 1 R) (2) (3) (4) . Experimental evidence supports the existence of antagonistic A 2A R/D 2 R and A 1 R/D 1 R interactions, respectively, in the GABA striopallidal and strionigro-strioentopeduncular neurons (1, 5) . Taken together, these data suggested proximity between receptors, which could allow them to form heteromeric complexes (directly or indirectly by means of adaptor proteins). In fact, A 1 R and D 1 R were found to form heteromeric complexes (6) . Although antagonistic A 2A R/D 2 R interactions have been reported to play an important role in basal ganglia function, it is still not known whether the formation of heteromeric A 2A R/ D 2 R complexes is also involved. In the present work, the existence of selective intramembrane interactions between A 2A R and D 2 R in neuronal cells is demonstrated, including formation of heteromeric A 2A R/D 2 R complexes and their potential involvement in cross-desensitization mechanisms via agonistinduced coaggregation and cointernalization of A 2A R and D 2 R. These results have clinical implications for Parkinson's disease and other basal ganglia disorders where dopamine D 2 R are the target for therapy (1, 5) .
EXPERIMENTAL PROCEDURES
Cell Cultures-Maintenance of SH-SY5Y cells (parental and D 2 Rtransfected cells) as well as the pharmacological characterization and maintenance of D 2 R-and D 1 R-transfected mouse fibroblast Ltk Ϫ cells are described in detail elsewhere (7) (8) (9) . For primary cultures, striata were removed from 16-day-old Sprague-Dawley rat embryos (B&K Universal) in Ca 2ϩ /Mg 2ϩ -free PBS supplemented with 20 units/ml penicillin and 20 g/ml streptomycin (Invitrogen). The tissue fragments were pooled and mechanically dissociated in SFM Neurobasal serum-free medium (Invitrogen), supplemented with B27 (Invitrogen), glutamine (2 mM; Invitrogen), penicillin/streptomycin (20 units/ml/20 g/ml; Invitrogen), and ␤-mercaptoethanol (25 M) (Invitrogen). Cells were collected by centrifugation at 100 ϫ g for 5 min and resuspended in fresh medium. The resulting single-cell suspension was seeded on 24-well plates coated with gelatin (Sigma) and poly-L-lysine (Sigma), and cells were grown at 37°C in saturation humidity with 5% CO 2 .
Immunolabeling Experiments-Neuroblastoma cells were grown on glass coverslips coated with poly-L-lysine (Sigma) and exposed to vari-ous amounts of CGS21680 (RBI) and/or quinpirole (RBI) in serum-free medium for 3 h at 37°C. They were then rinsed with PBS, fixed in 4% paraformaldehyde and 0.06 M sucrose for 15 min, and washed with PBS containing 20 mM glycine. Cells were subsequently treated with PBS, containing 20 mM glycine, and 1% bovine serum albumin for 30 min at room temperature. Double immunostaining was performed with fluorescein-conjugated anti-A 2A R antibodies (VC21-FITC, 40 g/ml) (10) and rhodamine-conjugated anti-D 2 R antibodies (D2-246-316, 30 g/ml) (11) for 1 h at 37°C. Antipeptide antisera against A 2A R were raised in New Zealand White rabbits and characterized as described elsewhere (12) . The specific peptide corresponds to the second extracellular loop of the receptor. Anti-A 2A R antibodies (VC21) were purified by affinity chromatography using the specific peptide coupled to activated thiolSepharose 4B. The coverslips were rinsed for 40 min in the same buffer and mounted with medium suitable for immunofluorescence (ICN). Internalization assays were made as reported elsewhere (12) with some modifications. Cells were incubated in serum-free medium (4°C, 2 h) with VC21-FITC and rhodamine-conjugated D2-246-316 in the absence (control) or presence of 200 nM CGS 21680 and/or 50 M quinpirole. Cells were washed with the same medium (without ligands in the control experiments), and internalization of labeled receptors was induced by incubation at 37°C for 3 h. Cells were fixed and processed as described above. Striatal cultures were exposed to various amounts of CGS21680 and/or quinpirole in the same medium for 6 h at 37°C. They were then rinsed with PBS, fixed with 4% paraformaldehyde containing 2% picric acid for 1 h, and washed with PBS supplemented with 20 mM glycine. Double or single immunostaining was performed with fluorescein-conjugated anti-A 2A R antibodies and rhodamine-conjugated anti-D 2 R (D2-246-316) antibodies or fluorescein-conjugated anti-A 1 R antibodies (PC21-FITC) (13) The area (light gray) where diffuse IR (no or few coaggregates) and the area (dark gray) where several coaggregates could be detected were interactively selected. The median intensity values (left y axis) for these two types of areas, obtained in the four experimental conditions mentioned above (c-g), are given. The Gini's indexes (right y axis) for the four experimental conditions (c-g) are given. It should be noticed that the Gini's index is low (rather even distribution of the IR intensity among pixels) for nontreated cells (c), whereas the Gini's index is high (rather uneven distribution of the IR intensity among pixels) for co-treatment with CGS-21680 (200 nM) plus quinpirole (50 M) (g). (14, 15) , which here measures the distribution of the IR intensity, pixel by pixel, in the sampled area. The Gini's index ranges from 0 (even distribution, i.e. the IR intensity is equally distributed among pixels) to 1 (maximal concentration, i.e. the IR intensity is concentrated in one single pixel) (14) .
Coimmunoprecipitation Experiments-SH-SY5Y neuroblastoma cell membranes were obtained by disrupting the cells with a Polytron homogenizer (Kinematica, PTA 20TS rotor, setting 4; Brinkmann) for three 5-s periods in 50 mM Tris-HCl, pH 7.4. Membranes were separated by centrifugation at 105,000 ϫ g for 45 min at 4°C. They were then solubilized in ice-cold lysis buffer (PBS, pH 7.4, Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) for 1 h on ice and then centrifuged at 80,000 ϫ g for 90 min. The supernatant was immunoprecipitated as previously described (6) (8, 9) . Immunoprecipitation of HA-A 2A R-HA was performed with anti-HA antibodies (Babco) covalently coupled to protein G-Sepharose. Immunoprecipitation and immunoblotting were done following standard protocols (6) . Immunoblots were developed with ECL Western blot detection system.
cAMP Accumulation Experiments-Neuroblastoma or striatal cells were incubated with [ 3 H]adenine (24 Ci/mmol; Amersham Biosciences; 1 Ci/well) for 2 h at 37°C in serum-free medium. They were subsequently washed with PBS and incubated for 10 min at 37°C in PBS containing 100 M phosphodiesterase inhibitor RO-20-1724 (Calbiochem). Various concentrations of forskolin, CGS 21680, and/or quinpirole were then added and the cells placed at 37°C for an additional 10 min. The incubation solution was then discarded and replaced by icecold 0. analysis were performed in nonpermeabilized cells, using fluorescein-conjugated anti-A 2A R antibodies (green color) and rhodamine-conjugated anti-D 2 R antibodies (red color). As seen in Fig. 1A (panels a and b) , there is a clear spatial predominance of D 2 R versus A 2A R immunoreactivity, which is in agreement with the higher D 2 R density found in previous binding experiments (7) . Confocal analysis revealed substantial colocalization of both receptors at the membrane level (yellow color in Fig. 1A, panel c) , which indicates that in the absence of exogenous agonists the lateral distance between the two receptor proteins is less than 0.1 m. A semi-quantitative analysis of the distribution of the yellow was done by evaluating the intensity of the color (which directly reflects the amount of coexisting receptors) and calculating the Gini's index or GI (a measure of unevenness, which evaluates the proportion of coaggregates in the sampled area). These calculations were completed on the whole cell body membrane, as well as on the areas of the cell body membrane containing coaggregates and on the parts with few or no coaggregates (Fig. 1B) . In nontreated cells (Fig. 1A, panel c) , high amounts of coexisting receptors were found both in the cell body membrane with coaggregates and in the cell body membrane displaying a more diffuse distribution of A 2A R/D 2 R IR. The GI value of these cells was 0.10, indicating a rather even distribution of the colocated A 2A R/D 2 R IR and few coaggregates of the two receptors (Fig. 1B) . Fig. 1A , panel e) induced an aggregation of both A 2A R and D 2 R. Similar effects were also observed with shorter incubation times at higher agonist concentrations (data not shown). Thus, 3 h of incubation at these concentrations give a maximal effect. The computer-assisted analysis of the confocal images showed an increase in unevenness of the yellow distribution (GI for the entire cell body membrane was 0.23 for CGS 21680-and 0.20 for quinpirole-treated cells). Furthermore, the yellow intensity value was still high for the cell body membrane with A 2A R/D 2 R coaggregates but very low for the cell body membrane with diffusely distributed A 2A R/D 2 R IR (Fig. 1B) . Altogether, this analysis indicates the presence on the cell body membrane of an increased proportion of A 2A R/D 2 R coaggregates.
Cointernalization of A 2A R and D 2 R in CGS 21680-or Quinpirole-treated SH-SY5Y Cells:
Immunolabeling ExperimentsCotreatment with CGS 21680 (100 nM) and quinpirole (10 M) markedly decreased the yellow intensity values of the cell body membrane associated with coaggregates and diffusely distributed A 2A R/D 2 R IR as compared with untreated cells (Fig. 1, A  (panel f) and B) . This indicates that cotreatment with CGS 21680 (100 nM) and quinpirole (10 M) induces coaggregation followed by cointernalization of A 2A R and D 2 R. A stronger reduction in D 2 R IR (red) was, however, obtained with higher concentrations of quinpirole (50 M) and CGS 21680 (200 nM) (Fig. 1A, panel g ). At these concentrations of the agonists, the Gini's index was high (0.30) reflecting an uneven distribution of A 2A R/D 2 R IR. In addition, the values for the yellow intensity in the cell body membrane with A 2A R/D 2 R coaggregates and the cell body membrane with diffusely distributed A 2A R/D 2 R IR were, respectively, low and very low (Fig. 1B) . This suggests that a cotreatment of the cells with high doses of the agonists potentiates both coaggregation and cointernalization of A 2A R and D 2 R. Ligand-induced cointernalization was confirmed in experiments where cells were first labeled with anti-A 2A R and anti-D 2 R antibodies for 2 h at 4°C in the absence (Fig. 2, panel  a) or in the presence of CGS21680 (200 nM) and/or quinpirole (50 M) (Fig. 2, panels b-d) . Subsequently, the ligand-induced internalization of labeled receptors was allowed to occur by incubating the cells for 3 h at 37°C. Confocal analysis revealed colocalized A 2A R/D 2 R aggregates inside the cell after pretreatment with either CGS 21680 (200 nM) or quinpirole (50 M) (Fig. 2, panels b and c) , which became more pronounced after pretreatment with both compounds (Fig. 2, panel d) .
Absence of Quinpirole-induced Aggregation of A 2A R in Parental SH-SY5Y Cells: Immunolabeling Experiments-The involvement of D 2 R in quinpirole-mediated effects was assessed using parental neuroblastoma SH-SY5Y cells, which express very low levels of D 2 R (7). Hence, quinpirole at 100 M for 3 h did not induce any modification of A 2A R immunolabeling pattern (Fig. 3) . (Fig. 4A) . Quinpirole (1 M) did not modify cAMP levels but significantly counteracted both forskolin (10 M)-induced and CGS 21680-induced increases in cAMP accumulation (Fig.  4A) . These results confirm the existence of functional and in- teracting A 2A R and D 2 R in D 2 R-transfected neuroblastoma cells (7) . After 3 h of incubation with either 200 nM CGS 21680 or 50 M quinpirole (and subsequent withdrawal of the agonists, see "Experimental Procedures"), CGS 21680 was no longer able to significantly increase cAMP levels (Fig. 4B) . This demonstrates the existence of both homologous and D 2 R-mediated heterologous desensitization of A 2A R. Instead, the inhibitory effect of quinpirole on forskolin-induced elevation of cAMP levels was about the same (40 -50% inhibition) under basal conditions and after a 3-h incubation with the A 2A R or the D 2 R agonist (Fig. 4, A and B) . Thus, as already described, A 2A R clearly desensitized after A 2A R agonist incubation (18, 19) and D 2 R (long form) showed resistance to D 2 R agonist-induced desensitization (20) . However, after 3 h of incubation with both quinpirole (50 M) and CGS 21680 (200 nM), quinpirole (1 M) inhibited forskolin-induced cAMP accumulation by only 17.1%/ 11.4% (median/interquartile range) (Fig. 4C) . This effect, when compared with the effect of quinpirole on untreated cells, was significantly different (Mann-Whitney U test: p Ͻ 0.01). Hence, quinpirole was found to inhibit forskolin-induced cAMP accumulation by 40.7%/5.8% (median/interquartile range) (Fig. 4C) . Therefore, costimulation of A 2A R and D 2 R accelerates D 2 R desensitization, likely by causing increased D 2 R internalization (see above).
Codesensitization of A 2A R and D 2 R in CGS 21680-and Quinpirole-treated SH-SY5Y Cells: cAMP Accumulation Experiments-Under basal conditions 1 M CGS 21680 significantly increased cAMP accumulation in SH-SY5Y neuroblastoma cells

Coimmunoprecipitation of A 2A R and D 2 R in Membrane Preparations from SH-SY5Y Neuroblastoma Cells and Ltk
Ϫ Fibroblast Cells-The possible existence of A 2A R/D 2 R heteromeric complexes was then analyzed by coimmunoprecipitation performed on membrane preparation of D 2 R-transfected SH-SY5Y neuroblastoma cells. Immunoprecipitation with anti-A 2A R antibodies followed by Western blotting with anti-D 2 R antibodies revealed three bands of 43, 47, and 63 kDa (Fig. 5 ), corresponding to different glycosylated states of the D 2 R (21). The same three bands were also obtained in control lysate preparations (Fig. 5) . On the other hand, immunoprecipitation with anti-A 2A R antibodies followed by Western blotting with anti-A 1 R did not reveal any band corresponding to A 1 R, indicating the absence of A 2A R-A 1 R co-immunoprecipitation (Fig. 5) . A Western blotting performed with control lysate preparations showed a band of ϳ40 kDa, which corresponds to the A 1 R (Fig. 5) . (Fig. 7A) . As for neuroblastoma cells, confocal analysis revealed a high degree of A 2A R/D 2 R colocalization in the absence of exposure to exogenous agonists (Fig. 7A) . Treatment (6 h) with either the A 2A R agonist CGS 21680 (100 nM) or the D 2 R agonist quinpirole (10 M) induced aggregation of both A 2A R and D 2 R (Fig. 7A ) and reduction in IR intensity. However, no synergism was observed when cells were cotreated with CGS 21680 (100 nM) and quinpirole (10 M) for the same time (Fig. 7A) . To assess the specificity of A 2A R/D 2 R interactions, cells were incubated with 10 M quinpirole for 6 h and immunostained with anti-A 1 R antibodies. No change in the pattern of distribution of A 1 R present in the soma and dendrites was observed (Fig. 7B) . In addition and instead of A 2A R/ D 2 R, no aggregates were seen, which confirms the specificity of A 2A R/D 2 R interactions. Cointernalization experiments analogous to those described in Fig. 2 could not be performed in cultured striatal cells, which did not tolerate the temperature conditions of the experimental internalization protocol (cells changed morphology and fell off the coverslip).
Interaction between A 2A R and D 2 R in Cultured Striatal Neurons: cAMP Accumulation Experiments-Both basal and forskolin-induced cAMP accumulation were about 10 times higher than in neuroblastoma cells (Fig. 8A ). This could explain why, unlike what was observed in neuroblastoma cells, CGS 21680 (1 M) did not induce any significant increase in cAMP accumulation compared with basal values (Fig. 8A) . As for neuroblastoma cells, quinpirole (1 M) did not modify cAMP levels but significantly reduced forskolin (10 M)-induced cAMP accumulation (Fig. 8B) . Finally, CGS 21680 (1 M) counteracted the effect of quinpirole on forskolin-induced cAMP accumulation (Fig. 8B) . These results provide a functional demonstration of the antagonistic A 2A R/D 2 R interactions in striatal neurons in culture. (1, 5) . Besides acute antagonistic actions, the A 2A R/D 2 R heteromers may be involved in receptor trafficking, because long term exposure to either A 2A R or D 2 R agonists induces aggregation and cotreatment with these agonists induces internalization of both receptors. Moreover, prior exposure to A 2A R or D 2 R agonists can produce a desensitization of the A 2A R in terms of cAMP accumulation associated with coaggregation. In contrast, co-exposure to A 2A R and D 2 R agonists, but not to any of the two agonists alone, causes desensitization of D 2 R-mediated inhibition of cAMP accumulation, which is associated with cointernalization. The present observation that A 2A R and D 2 R functions are simultaneously altered after long exposure to agonists can aid in understanding behavioral findings involving cross-tolerance and cross-sensitization between dopamine agonists and compounds active at adenosine receptors (such as caffeine) (24, 25) . Together with other recently reported findings, the present results suggest that changes in A 2A R function may be involved in the secondary effects observed after chronic intermittent treatment with L-DOPA such as reduced antiparkinsonian activity and dyskinesia (26) . Adenosine is a feedback detector of neuronal activation, in view of the fact that it allows the neuronal network to return into a resting state (27) . Adenosine is therefore expected to increase in the striatal extracellular fluid from patients with Parkinson's disease mainly after chronic intermittent L-DOPA treatment and in agreement with the evidence of increased striatal glutamate drive (28) . Hence, striatal extracellular levels of adenosine have been found to increase in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease (29) . Thus, the wearing off of the antiparkinsonian action of L-DOPA treatment may in part be caused by the simultaneous chronic activation of A 2A R and D 2 R that, according to the present results, may lead to substantial cointernalization of both receptors. The coadministration of A 2A R antagonists together with L-DOPA or dopamine D 2 R agonists may therefore provide a new therapeutic approach lacking the secondary effects of chronic L-DOPA treatment (30, 31) . Overall, the present and previous (1, 5) data implicate that the membrane interactions taking place between A 2A R and D 2 R via heteromeric complexes represent a crucial mechanism influencing D 2 Rmediated transmission. This prompts development of adenosine and dopamine antagonists/agonists compounds preferentially active on A 2A R/D 2 R heteromers as new drugs for the treatment of neuropsychiatric diseases, such as Parkinson's disease (30, 31) , schizophrenia (32, 33), Huntington's disease (34) , and dystonia (35) , in which D 2 R have been implicated.
